DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Monomethyl fumarate is an investigational drug.
There have been 6 clinical trials for Monomethyl fumarate. The most recent clinical trial was a Phase 1 trial, which was initiated on August 1st 2015.
The most common disease conditions in clinical trials are Multiple Sclerosis, Sclerosis, and Multiple Sclerosis, Relapsing-Remitting. The leading clinical trial sponsors are Biogen, Multiple Sclerosis Center of Northeastern New York, and Alkermes, Inc.
There are seven US patents protecting this investigational drug and thirty-three international patents.
Recent Clinical Trials for Monomethyl fumarate
|Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers||Banner Life Sciences LLC||Phase 1|
|Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008||Almirall, S.A.||Phase 1|
|Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers||Biogen||Phase 4|
Top disease conditions for Monomethyl fumarate
Top clinical trial sponsors for Monomethyl fumarate
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Monomethyl fumarate||Start Trial||Triterpenes having human antifungal and antiyeast activity||Naturtek, LLC (Duluth, MN)||Start Trial|
|Monomethyl fumarate||Start Trial||Triterpenes having antibacterial activity||Regents of the University of Minnesota (Minneapolis, MN)||Start Trial|
|Monomethyl fumarate||Start Trial||Renin inhibitors||Takeda Pharmaceutical Company Limited (Osaka, JP)||Start Trial|
|Monomethyl fumarate||Start Trial||Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use||XenoPort, Inc. (Santa Clara, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Monomethyl fumarate||Australia||9495301||2020-09-29||Start Trial|
|Monomethyl fumarate||Canada||2424013||2020-09-29||Start Trial|
|Monomethyl fumarate||European Patent Office||1322661||2020-09-29||Start Trial|
|Monomethyl fumarate||Japan||2004509972||2020-09-29||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|